Please login to the form below

Kyorin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Kyorin's Japan sales performance.

Bayer roll-out of haemophilia drug Jivi gathers pace

Bayer roll-out of haemophilia drug Jivi gathers pace. Japan’s MHLW is next to approve the drug. ... As in the US, the drug is approved in Japan for on-demand treatment and bleeding management during surgeries.

Tox trouble stalls Sosei/Allergan Alzheimer’s drug

The compound – called HTL0018318 – is in a phase 1 trial in the US run by Allergan and a phase 2 trial in Japan run by Sosei, but recruitment will be suspended

Teva wins FDA OK for crucial migraine drug

Italy, Spain, UK, and Japan).

AZ prepares to file COPD triple, taking on rival GSK

AZ has previously said it will file for approval in Japan and China before the end of this year, and in the US and Europe in early 2019.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Senior Writer, Healthcare Advertising, London: Excellent package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Senior Training Manager - Surrey: Competitive Salary &Bonus

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Systematic Review Lead- London: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Manager – Healthcare Advertising: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Account Manager: Negotiable

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Market Access Consultant - Greater Manchester: Negotiable

Account Manager- 4 days per week or full-time: Salary TBC

Account Director or Senior Account Director: Salary TBC

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Director, Healthcare Advertising Agency: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....